Jane Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jane Street’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,300	Closed	-$448K	–	9842
2024 Q4	$448K	Buy	+16,300	New	+$454K	﹤0.01%	7009
2022 Q2	–	Sell	-28,100	Closed	-$1.74M	–	10081
2022 Q1	$1.74M	Buy	+28,100	New	+$1.72M	﹤0.01%	5018
2021 Q4	–	Sell	-4,000	Closed	-$210K	–	10339
2021 Q3	$210K	Sell	4,000 -1,700	-30%	-$101K	﹤0.01%	8768
2021 Q2	$393K	Sell	5,700 -23,000	-80%	-$1.75M	﹤0.01%	7695
2021 Q1	$2.21M	Sell	28,700 -29,300	-51%	-$2.7M	﹤0.01%	3828
2020 Q4	$5.74M	Sell	58,000 -1,500	-3%	-$183K	﹤0.01%	1968
2020 Q3	$8.44M	Buy	+59,500	New	+$9.92M	0.01%	1356

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's LKFT Position: Q1 2026 in Review

Jane Street opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 13,607 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #8514 among its holdings. This is a return to the name: Jane Street previously reported a position in LKFT as recently as Q3 2025.

Jane Street first reported a position in LKFT in Q3 2015 and has held it in 28 quarters since. The position peaked at $20.8M in Q3 2018. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Jane Street held 13,607 shares of Lakefront Biotherapeutics American Depositary Shares worth $408K as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Jane Street position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8514 holding.
Jane Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 28 quarters since.
Jane Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.8M in Q3 2018.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.